Report: Pioneer Institute: Out-of-Pocket Pirates: Spotlight on Accumulator & Maximizer. Pioneer Institute Report, April 2023, William Smith, Robert Popovian and Wayne Winegarden. https://cutt.ly/z5rSEZf
Opinion Editorial: Transparency Laws Are the First Step toward Creating a More Sustainable Health-Care System. National Review, Feb 2023, Robert Popovian and Catherine Windels. https://cutt.ly/BwwszYX2
Opinion Editorial: It is Time for Policymakers to Protect Patients from Predatory Practices of Insurers and PBMs. Healthcare Business Today, January 2023, Robert Popovian and Louise Tharp. https://cutt.ly/ZwwsxpNU
Schulthess, D., Bowen, H.P., Popovian, R. et al. The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals. Therapeutic Innovation and Regulatory Science (2022). https://doi.org/10.1007/s43441-022-00451-8
McKinley Laura, Kelton John and Popovian Robert. Sowing confusion in the field: the interchangeable use of biosimilar terminology. January 2019. Current Medical Research and Opinion. https://pubmed.ncbi.nlm.nih.gov/30556742/
Cohen Hillel, Beydoun Donna, Chien David, Lessor Tracy, McCabe Dorothy, Muenzberg Michael, Popovian Robert and Uy Jonathan. Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physician.Advances In Therapy. January 2017, Volume 33, Issue 12, pp 2160–2172
Report: Academic Detailing: Pharma Fights Back, First Word Report, January 2012.
Abstract: Nichol MB, Shi S, Knight TK, Popovian R, and Morita R. Impact of Market Forces on Statin persistence patterns in a California Medicaid population.Value In Health. 2004, Vol 7, No 3, page 334.
Setter SM, Corbett C, Gates, B, Terriff C, Johns CA, Sclar DA, and Popovian R. Nonsteriodal Anti-inflammatory Drugs: The Need for Assessment and Education. Home Care Provider. 2001, VOL 6; PART 3, pages 100-105.
Abstract: Setter SM, Corbett CF, Terriff CM, Gates BJ, Johns C, Broemeling L, Maccini D and Popovian R. Abstract - Knowledge of nonsteroidal anti-inflammatory drugs in at risk elders: effectiveness of individualized patient education. Pharmacotherapy. Volume 20 (10), 2000, page 1229.
Abstract: Gerding, G, Carlson, J, Carter, C, Doak, M, Frederick, K and Popovian, R. Abstract – Treatment of Osteoarthritis and Rheumatoid Arthritis in a Long-term Care Setting.The Consultant Pharmacist. Volume 15 (9), 2000, page 933.
Johnson, KA, Nichol MB, Popovian R and Liu G. Letter to the Editor: The Impact of Pharmaceutical Capitation to Primary Medical Groups on the Health Care Expenditures of Medicare HMO Enrollees. Journal of Managed Care Pharmacy. Volume 6 (1), January/February 2000, pages 8-9.
Popovian R, Johnson, KA, Nichol MB and Liu G. The Impact of Pharmaceutical Capitation of Primary Medical Groups on the Health Care Expenditures of Medicare HMO Enrollees. Journal of Managed Care Pharmacy. Volume 5 (5), September/October 1999, pages 414-419.
Niedermann MS, McCombs JS, Unger AN, Kumar A and Popovian R. Treatment cost of acute exacerbations of chronic bronchitis. Clinical Therapeutics. Volume 21 (3), March 1999 1998, pages 576-591.
Niedermann MS, McCombs JS, Unger AN, Kumar A and Popovian R. The Cost of Treating Community Acquired Pneumonia. Clinical Therapeutics. Volume 20 (4), July/August 1998, pages 820-837.
Abstract: Popovian R, Hay, JW, Sung JCY and Jaresko GS,. Cost-effectiveness analyses of penicillin prophylaxis in dental procedures for prevention of infective endocarditis in mitral valve prolapse patients.Pharmacotherapy. Volume 17 (1), 1997, page 192.
Abstract: Jaresko GS, Sung JC, Tajbakhsh-Werner G, Popovian R and Goldshtein G. Implementing an Interdisciplinary, pharmacy directed Enterobactor surveillance program. International Pharmaceutical Abstracts. Volume 33 (21), 1996, page 2245.
Abstract: Jaresko GS, Popovian R, Nichol MB and Riley S. Factors influencing outcomes in patients with type I-lactamase producing gram negative bacteremia.Pharmacotherapy. Volume 15 (1), 1995, page 113.
Popovian R, Bedikian A, Gill MA. Management of Diabetic Foot Ulcers.California Pharmacist. February 1993, pages 28-35.
MORNING CONSULT – OPINION EDITORIALS
When Making Policy Decisions, Quality and Context of Data Should Be Scrutinized, November 2021 https://cutt.ly/yR1KuWq